Article
Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.
Journal of human genetics - 1 Jan 2005
Doi Kent, Noiri Eisei, Nakao Akihide, Fujita Toshiro, Kobayashi Shuzo, Tokunaga Katsushi
Abstract excerpt
NAD(P)H oxidase is one of the most important sources of reactive oxygen species and has been demonstrated to be upregulated by angiotensin II in the kidney. Given the effect of angiotensin-converting enzyme inhibitors on the progression of both diabetic and non-diabetic renal disease, we hypothesized that the polymorphisms of NAD(P)H oxidase are associated with development of end-stage renal disease (ESRD). We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
